Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tDCS for Late-Life Depression

NCT: NCT07657234 · NOT_YET_RECRUITING

NCT IDNCT07657234
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2027-09
SponsorAndre Russowsky Brunoni (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research study is to determine the effectiveness of Transcranial direct current stimulation (tDCS) therapy in the treatment of participants with Late-life depression (LLD). The study will evaluate feasibility, safety, and tolerability of high-dose (6mA) bilateral tDCS delivered as three daily sessions, 3 times a week, for 3 weeks in older adults (60 y/o and older) with late-life depression.

Frequently Asked Questions

What is tDCS for Late-Life Depression?

tDCS for Late-Life Depression is a clinical trial registered under NCT07657234. Current status: NOT_YET_RECRUITING.

What is the status of NCT07657234?

The current status of NCT07657234 (tDCS for Late-Life Depression) is: NOT_YET_RECRUITING.

When did tDCS for Late-Life Depression start?

tDCS for Late-Life Depression started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.